Literature DB >> 31728709

Ventriculoperitoneal shunt in treating of idiopathic normal pressure hydrocephalus-single-center study.

David Krahulik1, Miroslav Vaverka2, Lumir Hrabalek2, Martin Hampl2, Matej Halaj2, Jakub Jablonsky2, Katerina Langova3.   

Abstract

OBJECT: Idiopathic normal pressure hydrocephalus (iNPH) is the only variant of dementia disorders possibly treatable by neurosurgical intervention. iNPH is a neurodegenerative condition clinically characterized by gait ataxia, urinary incontinence, and memory disturbance. We present one of the largest single-center studies, which was designed to prove efficacy of our low-pressure setting of gravitational valve at all three symptoms of iNPH and to find statistically significant cut-off time for best clinical improvement according to the duration of symptoms.
METHODS: Sixty-one consecutive patients (mean age 74.9 ± 5.3) with iNPH were prospectively observed from the time of surgery with minimal 6 months follow-up. All patients underwent implantation of the same type of gravitational valve with the same setting-pro GAV with low opening pressure at 5 cm H2O-and were operated by the same team of 2 neurosurgeons. We statistically evaluated gait disturbance, psychological changes, and incontinence preoperatively and at 6 months after surgery and timing of the surgery according to the duration of symptoms and to the age.
RESULTS: Paired t test showed a statistically significant increase in MMSE, a statistically significant decrease in 10-m walk test and 360 deg. rotation test (p < 0.0001). The correlation among the change of the MMSE, the walk test, and the rotation test, and the age and time of symptoms' duration was verified by Pearson's correlation coefficient. Pearson's correlation coefficient showed a medium strong correlation between the change of MMSE and the time of symptoms (r = - 0.580; p < 0.0001) and between the change of the number of steps and the time of symptoms (r = 0.517, p < 0.0001). There was a statistically significant weak (poor) correlation between the change of the walk test and the time of symptoms (r = 0.351, p = 0.006). All 3 ROC tests confirmed optimal cut-off for the best improvement of symptoms as 9.5 months of the symptom duration.
CONCLUSIONS: We proved statistical significant optimal cut-off for the best improvement of the symptoms as 9.5 months of the symptom duration. This study also confirmed successful treatment of iNPH with VP shunting using low pressure setting of gravitational valve with overall improvement in 75% and low over drainage complications in 5% We proved statistically significant increase in MMSE, decrease in 10 m walk test and number of steps test, p < 0.0001.

Entities:  

Keywords:  Normal pressure hydrocephalus; VP shunt; prospective study

Year:  2019        PMID: 31728709      PMCID: PMC7197630          DOI: 10.1007/s00701-019-04135-5

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

Review 1.  Infectious immunity in the central nervous system and brain function.

Authors:  Robyn S Klein; Charise Garber; Nicole Howard
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 2.  [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].

Authors:  C Chen; X R Zhang; Z Y Ju; W F He
Journal:  Zhonghua Shao Shang Za Zhi       Date:  2020-06-20

3.  [Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization].

Authors:  Qing-ling Zhang; Yan-qing Ding; Jin-lin Hou; Li He; Zhong-xi Huang; Hui-jun Wang; Jun-jie Cai; Jin-hua Zhang; Wen-li Zhang; Jian Geng; Xin Li; Wei Kang; Lei Yang; Hong Shen; Zhuo-guo Li; Hui-xia Han; Yao-dan Lu
Journal:  Di Yi Jun Yi Da Xue Xue Bao       Date:  2003-11

4.  Multiple organ infection and the pathogenesis of SARS.

Authors:  Jiang Gu; Encong Gong; Bo Zhang; Jie Zheng; Zifen Gao; Yanfeng Zhong; Wanzhong Zou; Jun Zhan; Shenglan Wang; Zhigang Xie; Hui Zhuang; Bingquan Wu; Haohao Zhong; Hongquan Shao; Weigang Fang; Dongshia Gao; Fei Pei; Xingwang Li; Zhongpin He; Danzhen Xu; Xeying Shi; Virginia M Anderson; Anthony S-Y Leong
Journal:  J Exp Med       Date:  2005-07-25       Impact factor: 14.307

5.  Neurological Complications during Treatment of Middle East Respiratory Syndrome.

Authors:  Jee Eun Kim; Jae Hyeok Heo; Hye Ok Kim; Sook Hee Song; Sang Soon Park; Tai Hwan Park; Jin Young Ahn; Min Ky Kim; Jae Phil Choi
Journal:  J Clin Neurol       Date:  2017-07       Impact factor: 3.077

6.  A new coronavirus associated with human respiratory disease in China.

Authors:  Fan Wu; Su Zhao; Bin Yu; Yan-Mei Chen; Wen Wang; Zhi-Gang Song; Yi Hu; Zhao-Wu Tao; Jun-Hua Tian; Yuan-Yuan Pei; Ming-Li Yuan; Yu-Ling Zhang; Fa-Hui Dai; Yi Liu; Qi-Min Wang; Jiao-Jiao Zheng; Lin Xu; Edward C Holmes; Yong-Zhen Zhang
Journal:  Nature       Date:  2020-02-03       Impact factor: 49.962

7.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

8.  Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia.

Authors:  Mustafa Saad; Ali S Omrani; Kamran Baig; Abdelkarim Bahloul; Fatehi Elzein; Mohammad Abdul Matin; Mohei A A Selim; Mohammed Al Mutairi; Daifullah Al Nakhli; Amal Y Al Aidaroos; Nisreen Al Sherbeeni; Hesham I Al-Khashan; Ziad A Memish; Ali M Albarrak
Journal:  Int J Infect Dis       Date:  2014-10-07       Impact factor: 3.623

  8 in total
  5 in total

Review 1.  The Pathogenesis Based on the Glymphatic System, Diagnosis, and Treatment of Idiopathic Normal Pressure Hydrocephalus.

Authors:  Changwu Tan; Xiaoqiang Wang; Yuchang Wang; Chuansen Wang; Zhi Tang; Zhiping Zhang; Jingping Liu; Gelei Xiao
Journal:  Clin Interv Aging       Date:  2021-01-15       Impact factor: 4.458

2.  Clinical Outcomes of Shunting in Normal Pressure Hydrocephalus: A Multicenter Prospective Observational Study.

Authors:  Sokol Trungu; Antonio Scollato; Luca Ricciardi; Stefano Forcato; Filippo Maria Polli; Massimo Miscusi; Antonino Raco
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

3.  Gait, falls, cognitive function, and health-related quality of life after shunt-treated idiopathic normal pressure hydrocephalus-a single-center study.

Authors:  Caroline Hallqvist; Helena Grönstedt; Lisa Arvidsson
Journal:  Acta Neurochir (Wien)       Date:  2022-07-13       Impact factor: 2.816

4.  Lumbar-peritoneal shunt for idiopathic normal pressure hydrocephalus and secondary normal pressure hydrocephalus.

Authors:  Chia-Lin Liao; Pao-Hui Tseng; Hsin-Yi Huang; Tsung-Lang Chiu; Shinn-Zong Lin; Sheng-Tzung Tsai
Journal:  Tzu Chi Med J       Date:  2021-11-15

5.  Cerebral Venous Thrombosis Due to Overdrainage in a Patient With Normal Pressure Hydrocephalus: A Case Report.

Authors:  Ana Rita Silva; Mariana Santos; Maria João Machado; Ricardo Moreira; José Nuno Alves; Célia Machado; Ana Filipa Santos; Carla Ferreira; Ricardo Maré
Journal:  Cureus       Date:  2022-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.